STEMPOINT CAPITAL LP
An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026. SEC CIK 1952142.
- Reported value$580.5m
- Positions84
Holdings: 84 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31. The filing's table has 85 lines; lines for the same security and option type are added together here.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Tango Therapeutics IncTNGX | COM | 87583X109 | 38.2 | 6.6% | 1,223,019 | Added+1,022,100 | |
| Abivax SAABVX | SPONSORED ADS | 00370M103 | 37.8 | 6.5% | 283,657 | Reduced−30,134 | |
| Revolution Medicines IncRVMD | COM | 76155X100 | 30.0 | 5.2% | 159,943 | Reduced−121,689 | |
| Erasca IncERAS | COM | 29479A108 | 28.7 | 4.9% | 1,565,913 | Added+1,326,052 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 20.2 | 3.5% | 632,754 | Added+439,577 | |
| Dianthus Therapeutics IncDNTH | COM | 252828108 | 19.6 | 3.4% | 200,851 | Added+115,349 | |
| Enliven Therapeutics IncELVN | COM | 29337E102 | 17.6 | 3.0% | 346,914 | Reduced−16,524 | |
| Mineralys Therapeutics IncMLYS | COM | 603170101 | 16.3 | 2.8% | 602,686 | Added+69,308 | |
| Biohaven Ltd | COM | G1110E107 | 15.8 | 2.7% | 1,064,200 | Reduced−530,291 | |
| Surrozen IncSRZN | COM NEW | 86889P208 | 13.8 | 2.4% | 602,798 | Added+77,159 | |
| Kiniksa Pharmaceuticals International | ORD SHS CL A | G52694109 | 13.4 | 2.3% | 209,234 | New+209,234 | |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 13.2 | 2.3% | 239,146 | Reduced−796,350 | |
| Alkermes plc | SHS | G01767105 | 13.0 | 2.2% | 248,015 | Added+167,523 | |
| First Tracks BiotherapeuticsTRAX | ORD SHS | 337185102 | 12.5 | 2.2% | 622,723 | New+622,723 | |
| Praxis Precision Medicines IPRAX | COM NEW | 74006W207 | 12.5 | 2.1% | 37,243 | Reduced−19,024 | |
| Roivant Sciences Ltd | SHS | G76279101 | 12.3 | 2.1% | 348,408 | Reduced−37,392 | |
| Bioage Labs IncBIOA | COM | 09077V100 | 11.4 | 2.0% | 464,171 | Added+125,517 | |
| CG Oncology IncCGON | COM | 156944100 | 11.3 | 2.0% | 159,349 | Reduced−46,273 | |
| Oruka Therapeutics IncORKA | COM | 687604108 | 11.1 | 1.9% | 116,461 | New+116,461 | |
| Immunovant IncIMVT | COM | 45258J102 | 10.7 | 1.8% | 276,527 | Reduced−469,967 | |
| Celcuity IncCELC | COM | 15102K100 | 10.3 | 1.8% | 98,203 | Added+38,141 | |
| Relmada Therapeutics IncRLMD | COM | 75955J402 | 10.1 | 1.7% | 1,460,093 | Added+862,684 | |
| Climb Bio IncCLYM | COM | 28658R106 | 9.7 | 1.7% | 742,745 | New+742,745 | |
| Spyre Therapeutics IncSYRE | COM NEW | 00773J202 | 9.5 | 1.6% | 106,926 | Reduced−60,680 | |
| Zura Bio Ltd | CLASS A ORD SHS | G9TY5A101 | 8.1 | 1.4% | 1,368,215 | Added+614,695 | |
| Inflarx NV | COM | N44821101 | 7.2 | 1.2% | 3,228,255 | New+3,228,255 | |
| Amylyx Pharmaceuticals IncAMLX | COM | 03237H101 | 6.9 | 1.2% | 384,304 | Reduced−285,381 | |
| Celldex Therapeutics Inc NewCLDX | COM NEW | 15117B202 | 6.6 | 1.1% | 178,412 | Reduced−75,855 | |
| Ovid Therapeutics IncOVID | COM | 690469101 | 6.5 | 1.1% | 2,417,283 | New+2,417,283 | |
| Equillium IncEQ | COM | 29446K106 | 6.5 | 1.1% | 2,016,607 | New+2,016,607 | |
| Definium Therapeutics IncDFTX | COM SHS | 24477V105 | 6.5 | 1.1% | 137,124 | Reduced−188,359 | |
| Cytokinetics IncCYTK | COM NEW | 23282W605 | 6.4 | 1.1% | 75,603 | Reduced−53,974 | |
| Damora Therapeutics Inc | COM NEW | 36322Q206 | 5.6 | 1.0% | 216,194 | New+216,194 | |
| Inventiva SAIVA | ADS | 46124U107 | 5.4 | 0.9% | 1,426,320 | New+1,426,320 | |
| Century Therapeutics IncIPSC | COM | 15673T100 | 5.3 | 0.9% | 2,146,182 | New+2,146,182 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 5.1 | 0.9% | 714,280 | New+714,280 | |
| Eyepoint IncEYPT | COM NEW | 30233G209 | 4.8 | 0.8% | 338,471 | Reduced−472,293 | |
| Assembly Biosciences IncASMB | COM NEW | 045396207 | 4.7 | 0.8% | 170,378 | Reduced−15,057 | |
| Whitehawk Therapeutics IncWHWK | COM | 00032Q104 | 4.7 | 0.8% | 1,021,037 | Added+81,668 | |
| Xenon Pharmaceuticals IncXENE | COM | 98420N105 | 4.6 | 0.8% | 76,075 | Reduced−64,680 | |
| Uniqure NV | SHS | N90064101 | 4.1 | 0.7% | 88,115 | Added+10,049 | |
| Compass Pathways plcCMPS | SPONSORED ADS | 20451W101 | 4.0 | 0.7% | 284,769 | New+284,769 | |
| Avalyn Pharmaceuticals IncAVLN | COM SHS | 05348Y105 | 3.9 | 0.7% | 118,000 | New+118,000 | |
| Maplight Therapeutics IncMPLT | COM | 56565P103 | 3.8 | 0.7% | 106,906 | Added+6,906 | |
| Alumis IncALMS | COM | 022307102 | 3.8 | 0.7% | 135,736 | Reduced−93,830 | |
| Axsome Therapeutics Inc.AXSM | COM | 05464T104 | 3.8 | 0.6% | 15,375 | New+15,375 | |
| Monte Rosa Therapeutics IncGLUE | COM | 61225M102 | 3.7 | 0.6% | 153,544 | New+153,544 | |
| Acadia Pharmaceuticals IncACAD | COM | 004225108 | 3.6 | 0.6% | 143,167 | Reduced−99,399 | |
| Solid Biosciences IncSLDB | COM NEW | 83422E204 | 3.6 | 0.6% | 358,780 | Added+163,377 | |
| Personalis IncPSNL | COM | 71535D106 | 3.3 | 0.6% | 247,783 | New+247,783 | |
| Crescent Biopharma Inc. | COM | G2545C104 | 3.3 | 0.6% | 182,382 | New+182,382 | |
| Arrowhead Pharmaceuticals inARWR | COM | 04280A100 | 3.2 | 0.6% | 39,198 | New+39,198 | |
| Kodiak Sciences IncKOD | COM | 50015M109 | 3.0 | 0.5% | 75,872 | New+75,872 | |
| Pharvaris N V | COM | N69605108 | 2.8 | 0.5% | 80,907 | Reduced−5,730 | |
| Monopar Therapeutics IncMNPR | COM NEW | 61023L207 | 2.8 | 0.5% | 30,125 | New+30,125 | |
| Rapport Therapeutics IncRAPP | COM | 75383L102 | 2.8 | 0.5% | 66,582 | New+66,582 | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 2.6 | 0.5% | 77,589 | Reduced−103,069 | |
| Sionna Therapeutics IncSION | COM | 829401108 | 2.6 | 0.5% | 59,426 | Added+22,886 | |
| Arcutis Biotherapeutics IncARQT | COM | 03969K108 | 2.6 | 0.4% | 98,945 | Reduced−314,847 | |
| C4 Therapeutics IncCCCC | COM STK | 12529R107 | 2.4 | 0.4% | 523,648 | Added+70,412 | |
| Spruce Biosciences IncSPRB | COM NEW | 85209E208 | 2.2 | 0.4% | 41,388 | Added+35,028 | |
| CUE Biopharma IncCUE | COM | 22978P205 | 2.1 | 0.4% | 66,995 | New+66,995 | |
| Structure Therapeutics IncGPCR | SPONSORED ADS | 86366E106 | 2.0 | 0.4% | 38,178 | Reduced−162,089 | |
| Protagonist Therapeutics IncPTGX | COM | 74366E102 | 2.0 | 0.3% | 16,303 | Reduced−56,274 | |
| Helix Acquisition Corp III | USD CL A ORD SHS | G4444S107 | 1.8 | 0.3% | 171,671 | Reduced−133,357 | |
| Biodesix IncBDSX | COM | 09075X207 | 1.6 | 0.3% | 70,000 | Reduced−4 | |
| Tenax Therapeutics IncTENX | COM NEW | 88032L605 | 1.4 | 0.2% | 96,273 | Reduced−92,427 | |
| SAB Biotherapeutics IncSABS | COM NEW | 78397T202 | 1.3 | 0.2% | 342,631 | Reduced−32,369 | |
| Calcimedica Inc | COM NEW | 38942Q202 | 1.2 | 0.2% | 1,244,864 | New+1,244,864 | |
| LB Pharmaceuticals IncLBRX | COM SHS | 50180M108 | 1.0 | 0.2% | 31,785 | Reduced−18,215 | |
| Cellectar Biosciences IncCLRB | COM NEW | 15117F880 | 1.0 | 0.2% | 354,938 | New+354,938 | |
| Personalis IncPSNL | COM | 71535D106 | 0.8 | 0.1% | 470,000 | Call | New+470,000 |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | 0.8 | 0.1% | 431,054 | New+431,054 | |
| Biohaven Ltd | COM | G1110E107 | 0.5 | <0.1% | 500,000 | Call | New+500,000 |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 0.4 | <0.1% | 250,000 | Put | New+250,000 |
| Astrazeneca plc | ORD | G0593M107 | 0.2 | <0.1% | 25,000 | Call | New+25,000 |
| SPDR Series Trust | ST STR SP BIOT | 78464A870 | 0.2 | <0.1% | 400,000 | Call | Added+250,000 |
| Tango Therapeutics IncTNGX | COM | 87583X109 | 0.2 | <0.1% | 100,000 | Call | New+100,000 |
| Revolution Medicines IncRVMD | COM | 76155X100 | 0.1 | <0.1% | 30,000 | Put | Reduced−70,000 |
| Erasca IncERAS | COM | 29479A108 | 0.1 | <0.1% | 200,000 | Put | New+200,000 |
| Ark ETF TR | GENOMIC REV ETF | 00214Q302 | 0.1 | <0.1% | 100,000 | Put | New+100,000 |
| Roivant Sciences Ltd | SHS | G76279101 | 0.0 | <0.1% | 100,000 | Put | New+100,000 |
| Vistagen Therapeutics IncVTGN | COM | 92840H400 | 0.0 | <0.1% | 616,749 | Unchanged | |
| Amgen IncAMGN | COM | 031162100 | 0.0 | <0.1% | 15,000 | Put | New+15,000 |
Sold out: 64 positions
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 0.0 | 0.0% | 0 | Sold out−134,742 | |
| Avalo Therapeutics IncAVTX | COM NEW | 05338F306 | 0.0 | 0.0% | 0 | Sold out−134,742 | |
| Boston Scientific CorpBSX | COM | 101137107 | 0.0 | 0.0% | 0 | Call | Sold out−250,000 |
| Boston Scientific CorpBSX | COM | 101137107 | 0.0 | 0.0% | 0 | Call | Sold out−250,000 |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 0.0 | 0.0% | 0 | Sold out−37,592 | |
| Capricor Therapeutics IncCAPR | COM NEW | 14070B309 | 0.0 | 0.0% | 0 | Sold out−37,592 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 0.0 | 0.0% | 0 | Sold out−426,561 | |
| Denali Therapeutics IncDNLI | COM | 24823R105 | 0.0 | 0.0% | 0 | Sold out−426,561 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 0.0 | 0.0% | 0 | Sold out−506,075 | |
| Dyne Therapeutics IncDYN | COM | 26818M108 | 0.0 | 0.0% | 0 | Sold out−506,075 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 0.0 | 0.0% | 0 | Sold out−290,864 | |
| Edgewise Therapeutics IncEWTX | COM | 28036F105 | 0.0 | 0.0% | 0 | Sold out−290,864 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 0.0 | 0.0% | 0 | Call | Sold out−10,000 |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 0.0 | 0.0% | 0 | Call | Sold out−10,000 |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 0.0 | 0.0% | 0 | Sold out−14,588 | |
| Edwards Lifesciences CorpEW | COM | 28176E108 | 0.0 | 0.0% | 0 | Sold out−14,588 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 0.0 | 0.0% | 0 | Sold out−193,777 | |
| Evommune IncEVMN | COM SHS | 30054Y107 | 0.0 | 0.0% | 0 | Sold out−193,777 | |
| Forte Biosciences Inc | COM NEW | 34962G208 | 0.0 | 0.0% | 0 | Sold out−58,020 | |
| Forte Biosciences Inc | COM NEW | 34962G208 | 0.0 | 0.0% | 0 | Sold out−58,020 | |
| Immunocore Holdings plcIMCR | ADS | 45258D105 | 0.0 | 0.0% | 0 | Sold out−63,543 | |
| Immunocore Holdings plcIMCR | ADS | 45258D105 | 0.0 | 0.0% | 0 | Sold out−63,543 | |
| Immunovant IncIMVT | COM | 45258J102 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Immunovant IncIMVT | COM | 45258J102 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Invesco QQQ TR | UNIT SER 1 | 46090E103 | 0.0 | 0.0% | 0 | Call | Sold out−40,000 |
| Invesco QQQ TR | UNIT SER 1 | 46090E103 | 0.0 | 0.0% | 0 | Call | Sold out−40,000 |
| Invivyd IncIVVD | COM | 00534A102 | 0.0 | 0.0% | 0 | Sold out−1,874,546 | |
| Invivyd IncIVVD | COM | 00534A102 | 0.0 | 0.0% | 0 | Sold out−1,874,546 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 0.0 | 0.0% | 0 | Sold out−26,385 | |
| Ionis Pharmaceuticals IncIONS | COM | 462222100 | 0.0 | 0.0% | 0 | Sold out−26,385 | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 0.0 | 0.0% | 0 | Sold out−154,034 | |
| Jade Biosciences IncJBIO | COM NEW | 008064206 | 0.0 | 0.0% | 0 | Sold out−154,034 | |
| Johnson & JohnsonJNJ | COM | 478160104 | 0.0 | 0.0% | 0 | Sold out−15,415 | |
| Johnson & JohnsonJNJ | COM | 478160104 | 0.0 | 0.0% | 0 | Sold out−15,415 | |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 0.0 | 0.0% | 0 | Sold out−160,420 | |
| Lipocine Inc NewLPCN | COM NEW | 53630X203 | 0.0 | 0.0% | 0 | Sold out−160,420 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 0.0 | 0.0% | 0 | Sold out−499,469 | |
| MBX Biosciences IncMBX | COM | 55287L101 | 0.0 | 0.0% | 0 | Sold out−499,469 | |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 0.0 | 0.0% | 0 | Sold out−315,226 | |
| Nurix Therapeutics IncNRIX | COM | 67080M103 | 0.0 | 0.0% | 0 | Sold out−315,226 | |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 0.0 | 0.0% | 0 | Call | Sold out−25,000 |
| Olema Pharmaceuticals IncOLMA | COM | 68062P106 | 0.0 | 0.0% | 0 | Call | Sold out−25,000 |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Scholar Rock HLDG CorpSRRK | COM | 80706P103 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Sensei Biotherapeutics IncFTH | COM NEW | 81728A207 | 0.0 | 0.0% | 0 | Sold out−132,873 | |
| Sensei Biotherapeutics IncFTH | COM NEW | 81728A207 | 0.0 | 0.0% | 0 | Sold out−132,873 | |
| State STR SPDR S&P 500 ETF TSPY | TR UNIT | 78462F103 | 0.0 | 0.0% | 0 | Call | Sold out−50,000 |
| State STR SPDR S&P 500 ETF TSPY | TR UNIT | 78462F103 | 0.0 | 0.0% | 0 | Call | Sold out−50,000 |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 0.0 | 0.0% | 0 | Sold out−23,295 | |
| Sutro Biopharma IncSTRO | COM SHS | 869367201 | 0.0 | 0.0% | 0 | Sold out−23,295 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 0.0 | 0.0% | 0 | Call | Sold out−150,000 |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 0.0 | 0.0% | 0 | Sold out−1,215,743 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 0.0 | 0.0% | 0 | Sold out−1,215,743 | |
| Syndax Pharmaceuticals IncSNDX | COM | 87164F105 | 0.0 | 0.0% | 0 | Call | Sold out−150,000 |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Terns Pharmaceuticals Inc | COM | 880881107 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Twist Bioscience CorpTWST | COM | 90184D100 | 0.0 | 0.0% | 0 | Sold out−43,110 | |
| Twist Bioscience CorpTWST | COM | 90184D100 | 0.0 | 0.0% | 0 | Sold out−43,110 | |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Tyra Biosciences IncTYRA | COM | 90240B106 | 0.0 | 0.0% | 0 | Call | Sold out−100,000 |
| Vaxcyte IncPCVX | COM | 92243G108 | 0.0 | 0.0% | 0 | Sold out−59,061 | |
| Vaxcyte IncPCVX | COM | 92243G108 | 0.0 | 0.0% | 0 | Sold out−59,061 | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 0.0 | 0.0% | 0 | Sold out−850,742 | |
| X4 Pharmaceuticals IncXFOR | COM NEW | 98420X202 | 0.0 | 0.0% | 0 | Sold out−850,742 |
Source: SEC EDGAR, Form 13F-HR, accession 0001420506-26-001687 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.